Boceprevir Treatment in Participants With Chronic Hepatitis C Genotype 1 Deemed Nonresponders to Peginterferon/Ribavirin (P05514)
Clinical trial NCT00910624 · COMPLETED
Trial details
- NCT number
- NCT00910624
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-06-22
- Primary completion
- 2012-12-07
- Enrollment
- 168
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.